Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).

Joel SchlessingerJulie S ShepardRichard GowerJohn C SuCharles LyndeAmy ChaWilliam C PortsVivek PurohitLiza TakiyaJohn L WerthChuanbo ZangBonnie Vlahosnull null

Published in: American journal of clinical dermatology (2021)

NCT03356977.

Keyphrases

atopic dermatitis
open label
healthcare
randomized controlled trial
systematic review
clinical trial
palliative care
quality improvement
study protocol
phase ii
phase ii study
radiation therapy